Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-23-024028
Filing Date
2023-06-30
Accepted
2023-06-30 16:06:21
Documents
1
Period of Report
2023-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1688155573.html 3  
1 FORM 3 wk-form3_1688155573.xml 3 2281
  Complete submission text file 0001628280-23-024028.txt   3709
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACERAGEN, INC. 15 TW ALEXANDER DRIVE DURHAM NC 27709
Business Address
Kraus Carl N (Reporting) CIK: 0001946475 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38599 | Film No.: 231061734